NCT07819513 Spatial Computing With the Apple Vision Pro in Image-guided Procedures
| NCT ID | NCT07819513 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Apple Vision Pro |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-09-11 |
| Primary Completion | 2027-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2026-09-11 with a primary completion date of 2027-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To learn if it is possible to use Apple Vision Pro (AVP) technology during image-guided procedures.
Eligibility Criteria
Inclusion Criteria: Participants: • 18-years-old and older, any sex, race, or ethnicity, undergoing CT-guided biopsy of the abdomen or pelvis. Primary operators: • Attending physicians in Interventional Radiology who have completed mandatory training and familiarization. Exclusion Criteria: • Participants unable to provide informed consent or contraindications to planned procedures.
Contact & Investigator
Aaron K Jones, MD
PRINCIPAL INVESTIGATOR
UT MD Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT07819513 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Apple Vision Pro. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07819513 currently recruiting?
Yes, NCT07819513 is actively recruiting participants. Contact the research team at Kyle.Jones@mdanderson.org for enrollment information.
Where is the NCT07819513 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT07819513 clinical trial?
NCT07819513 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Aaron K Jones, MD at UT MD Anderson Cancer Center. The trial plans to enroll 30 participants.